atrasentan has been researched along with phenylephrine in 3 studies
Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (phenylephrine) | Trials (phenylephrine) | Recent Studies (post-2010) (phenylephrine) |
---|---|---|---|---|---|
358 | 41 | 108 | 13,797 | 857 | 2,083 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carneiro, FS; Carneiro, ZN; Carvalho, MH; Ergul, A; Fortes, ZB; Giachini, FR; Lima, VV; Pollock, DM; Saleh, MA; Tostes, RC; Webb, RC | 1 |
Kang, JJ; Kang, PM; Ke, Q; Kim, UK; Samad, MA | 1 |
El-Din, MM; El-Mas, MM; Elmallah, AI; Khedr, MM; Nasser, SA; Sabra, R | 1 |
3 other study(ies) available for atrasentan and phenylephrine
Article | Year |
---|---|
O-GlcNAcylation contributes to augmented vascular reactivity induced by endothelin 1.
Topics: Acetylglucosamine; Animals; Aorta, Thoracic; Atrasentan; Blood Pressure; Blotting, Western; Desoxycorticosterone; Drug Synergism; Endothelin-1; Glycoproteins; Glycosylation; Hypertension; In Vitro Techniques; Male; N-Acetylglucosaminyltransferases; Phenylephrine; Pyrrolidines; Rats; Rats, Wistar; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 2010 |
Endothelin A receptor antagonist, atrasentan, attenuates renal and cardiac dysfunction in Dahl salt-hypertensive rats in a blood pressure independent manner.
Topics: Animals; Atrasentan; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Disease Models, Animal; Echocardiography; Endothelin A Receptor Antagonists; Gene Expression; Heart Diseases; Hemodynamics; Hypertension; Hypertrophy; Kidney Function Tests; Male; Myocytes, Cardiac; Phenylephrine; Pyrrolidines; Rats; Receptor, Endothelin A; Renal Insufficiency, Chronic | 2015 |
Facilitation by the renin-angiotensin system of cyclosporine-evoked hypertension in rats: Role of arterial baroreflexes and vasoreactivity.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Angiotensin II; Animals; Aorta; Atrasentan; Baroreflex; Blood Pressure; Captopril; Cyclosporine; Hypertension; Indomethacin; Losartan; Male; Naphthalenes; Nitric Oxide Synthase Type III; Nitroprusside; Oligopeptides; Phenylephrine; Piperidines; Propionates; Pyrrolidines; Rats; Renin-Angiotensin System; Vasoconstriction; Vasodilation | 2016 |